Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: Ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 9, 2007, Pages 786-791

  Sipsas, Nikolaos V ^a   Kosmas, Christos ^b   Ziakas, Panayiotis D ^a   Karabelis, Athanasios ^b   Vadiaka, Maria ^a   Skopelitis, Elias ^a   Kordossis, Theodore ^a   Tsavaris, Nikolaos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b METAXA CANCER HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTINEOPLASTIC AGENT; CEFUROXIME AXETIL; CIPROFLOXACIN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BREAST CANCER; CANCER PATIENT; COLON CANCER; CONTROLLED STUDY; DEATH; DIARRHEA; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; HOSPITAL DEPARTMENT; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MULTIVARIATE ANALYSIS; NAUSEA; NEUTROPHIL COUNT; OUTPATIENT CARE; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADMINISTRATION, ORAL; ADULT; AGED; AMBULATORY CARE; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CEFUROXIME; CIPROFLOXACIN; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; RETROSPECTIVE STUDIES;

EID: 34548131713     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701367769     Document Type: Article

References (22)

1. Sickles, EA, Greene, WH and Wiernik, PH. (1975) Clinical presentation of infection in granulopenic patients. Arch Intern Med, 135, pp. 715-719.
2. Sipsas, NV, Bodey, GP and Kontoyiannis, DP. (2005) Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer, 103, pp. 1103-1113.
3. Talcott, JA, Finberg, R., Mayer, RJ and Goldman, L. (1988) The medical course of cancer patients with fever and neutropenia. Clinical identification of a low risk subgroup at presentation. Arch Intern Med, 148, pp. 2561-2568.
4. Klastersky, J., Paesmans, M., Rubenstein, EB, Boyer, M., Elting, L. and Feld, R. (2000) The multinational association for supportive care in cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol, 18, pp. 3038-3051.
5. Rolston, KVI. (1999) New trends in patient management: Risk-based therapy for febrile patients with neutropenia. Clin Infect Dis, 29, pp. 515-521.
6. Kern, WV. (2006) Risk assessment and treatment of low-risk patients with febrile neutropenia. Clin Infect Dis, 42, pp. 533-540.
7. Vidal, L., Paul, M., Ben, DI, Soares-Weiser, K. and Leibovici, L. (2004) Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: A systematic review and meta-analysis of randomized trials. J Antimicrob Chemother, 54, pp. 29-37.
8. Scott, LJ, Ormrod, D. and Goa, KL. (2001) Cefuroxime axetil: An updated review of its use in the management of bacterial infections. Drugs, 61, pp. 1455-1500.
9. Freifeld, A., Marchigiani, D., Walsh, T., Chanock, S., Lewis, L. and Hiemenz, J. (1999) A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med, 341, pp. 305-311.
10. Kern, WV, Cometta, A., De Bock, R., Langenaeken, J., Paesmans, M. and Gaya, H. (1999) Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med, 341, pp. 312-318.
11. Finberg, RW and Talcott, JA. (1999) Fever and neutropenia: How to use a new treatment strategy. N Engl J Med, 341, pp. 362-363.
12. Talcott, JA, Whalen, A., Clark, J., Rieker, PP and Finberg, R. (1994) Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: A pilot study of 30 patients based on a validated prediction rule. J Clin Oncol, 12, pp. 107-114.
13. Rubenstein, EB, Rolston, K., Benjamin, RS, Loewy, J., Escalante, C. and Manzullo, R. (1993) Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer, 71, pp. 3640-3646.
14. Malik, IA, Khan, WA, Karim, M., Aziz, Z. and Khan, MA. (1995) Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: Results of a prospective randomized trial. Am J Med, 98, pp. 224-231.
15. The EORTC International Antimicrobial Therapy Project group (1978) Three antibiotic regimens in the treatment of infection in febrile granulopenic patients with cancer. J Infect Dis, 137, pp. 14-29.
16. Bodey, GP and Rolston, KVI. (2001) Management of fever in neutropenic patients. J Infect Chemother, 7, pp. 1-9.
17. Klastersky, J. (1986) Concept of empirical therapy with antibiotic combinations: Indications and limits. Am J Med, 80, pp. 2-12.
18. Wisplinghoff, H., Seifert, H., Wenzel, RP and Edmond, MB. (2003) Current trends in epidemiology of nosocomial bloodstream infections in patients with haematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis, 36, pp. 1103-1110.
19. Girmenia, C., Russo, E., Carmosino, I., Breccia, M., Dragoni, F. and Latagliata, R. (2007) Early hospital discharge with oral antimicrobial therapy in patients with haematological malignancies and low-risk febrile neutropenia. Ann Hematol, 86, pp. 263-270.
20. Bodey, GP, Buckley, M., Sathe, YS and Freireich, EJ. (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukaemia. Ann Intern Med, 64, pp. 328-340.
21. Chamilos, G., Bamias, A., Efstathiou, E., Zorzou, PM, Kastritis, E. and Kostis, E. (2005) Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin. Cancer, 103, pp. 2629-2635.
22. Claxton, AJ, Cramer, J. and Pierce, C. (2001) Impact of dose frequency upon adherence. Analysis of 76 studies of electronic monitoring of adherence. Clin Ther, 23, pp. 1296-1310.